Chinese Peptide Company
FDA inspection history in Hangzhou, China, 2012 to 2024
- 1
- Form 483
- 1
- Warning letter
Every document, by year
- Form 483
- Warning letter
2012: one warning letter; 2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2012One warning letter, at Hangzhou, China.
- 2024One Form 483, at Hangzhou, China.
Cited most
Across all Chinese Peptide observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.63Equipment design, size, and location1
The complete Chinese Peptide file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Hangzhou, China
One Form 483 and one warning letter · 2012 to 2024 · 2 observations
Latest: Form 483, Jun 14, 2024 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-06-14 | 483 Form 483 | Hangzhou, China | 2 | $99 |
| 2012-02-28 | Warning letter Warning letter | Hangzhou, China | — | $99 |
Investigators on these documents
FEI number 3004518843 · most recent document Jun 14, 2024
About Chinese Peptide Company
How many FDA Form 483s has Chinese Peptide Company received?
FDA Intel has 1 Form 483 on file for Chinese Peptide Company; the most recent is dated Jun 14, 2024.
When was Chinese Peptide Company last inspected by FDA?
The most recent FDA inspection document on file for Chinese Peptide Company is a Form 483 dated Jun 14, 2024, for the site in Hangzhou, China.
What did FDA cite at Chinese Peptide Company?
The regulations cited most in the observations on file for Chinese Peptide Company are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.63 (Equipment design, size, and location), 1 time.
Has Chinese Peptide Company received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Chinese Peptide Company; the most recent is dated Feb 28, 2012.